Scarlet Raises $50M to Accelerate AI Medical Device Certification
Scarlet raised $50M Series B led by Headline to accelerate AI medical device certification and expand globally.
The big picture: Scarlet, a certification body for AI and software medical devices, today announced a $50 million Series B round. The funding was led by Headline, with participation from new investor Notion Capital and existing investors Atomico, Creandum, Kindred Capital, and Entrepreneurs First. Nancy Xiao Mclaughlin, Partner at Headline, joins Scarlet’s board.
Why it matters:
- Certification bottleneck: The rapid development of AI diagnostic models often outpaces the capacity of traditional certification bodies, leading to 12-18 month assessment delays and hindering healthcare innovation.
- Specialized expertise: Scarlet is reportedly the only EU-designated certification body that specializes in software and AI, built to support the iterative development cycles inherent to AI products.
- Global recognition: The company holds designations from the EU, the UK’s MHRA, and is recognized by the US FDA as a Third Party Review Organisation, streamlining market access for its clients.
How it works:
- AI-enabled platform: Scarlet’s platform allows customers to upload technical documentation in various formats for assessment by qualified reviewers against relevant regulations.
- Comprehensive certification: The company certifies cutting-edge AI products, including LLMs and computer-vision models, and also assesses the processes by which these AI products are built.
- Continuous compliance: A subscription model provides ongoing surveillance, annual audits, and support for product changes, ensuring consistent assessments and regulatory transparency.
The catch: While Scarlet’s specialized approach addresses a critical market need, scaling its roster of expert AI reviewers and engineers globally will be crucial. Maintaining rigorous standards while accelerating certification for a rapidly evolving and complex technology like AI will require continuous adaptation and investment to stay ahead of both innovation and regulatory changes.
Key Facts
- Company: Scarlet
- Amount: $50M
- Round: Series B
- Investors: Headline (lead), Notion Capital, Atomico, Creandum, Kindred Capital, Entrepreneurs First
- Founders: James Dewar, Jamie Cox
- Announced: 2026-10-12
- Sector: AI Medical Device Certification
- Headquarters: London, UK
AIPressRoom Weekly
Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.